Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference

Corvus will hold one-on-one investor meetings and webcast fireside chats as it highlights soquelitinib, now in Phase 2 and Phase 3 trials.

Summary by The Norfolk Daily News
SOUTH SAN FRANCISCO, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a

4 Articles

WBOC 16WBOC 16
Reposted by
Carroll County Mirror-DemocratCarroll County Mirror-Democrat
Center

Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference

BOSTON and SAN DIEGO, May 20, 2026 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the

Read Full Article
The Norfolk Daily NewsThe Norfolk Daily News
Reposted by
mykxlg.commykxlg.com
Center

Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Norfolk Daily News broke the news on Wednesday, May 20, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Pharma icon

Pharma

Boston, Massachusetts icon

Boston, Massachusetts

Health & Medicine icon

Health & Medicine

Business & Markets icon

Business & Markets

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal